Deep vein thrombosis in Europe—health-related quality of life and mortality

M Monreal, G Agnelli, LH Chuang, AT Cohen, PD Gumbs, R Bauersachs, P Mismetti, AK Gitt, S Kroep, SN Willich, B Van Hout
2019-11-20
Abstract:ObjectivesDeep vein thrombosis (DVT) is a major health-care burden in Europe, but exact estimates are lacking. This study reports results from the PREFER venous thromboembolism (VTE) study concerning health-related quality of life (HrQoL) and mortality of patients with DVT.MethodsPREFER VTE was a prospective, observational study, conducted in 7 European countries, designed to provide data concerning treatment patterns, resource utilization, mortality, and QoL. First-time or recurrent patients with DVT were followed at 1, 3, 6, and 12 months. Health-related QoL—as measured by the EuroQoL 5-Dimension 5-Level instrument ( EQ-5D-5L)—was analyzed using Tobit regression with repeated measures, assessing the impact of baseline characteristics stratified by cancer activity. Mortality was analyzed using logistic regression.ResultsAt baseline, patients with DVT had a 0.14 lower EQ-5D-5L index score (0 …
What problem does this paper attempt to address?